Today's Reuters Health News Headlines - Yahoo! News:
|
|
Japan prosecutors charge key figures in Olympus scandal
Tue,6 Mar 2012 10:33 PM PST
Reuters - TOKYO (Reuters) - Tokyo prosecutors on Wednesday charged Olympus Corp and six key figures in the $1.7 billion accounting fraud at the camera and endoscope maker, tightening their case in the investigation of one of Japan's biggest corporate scandals. Prosecutors charged ex-chairman Tsuyoshi Kikukawa, former executive vice-president Hisashi Mori and former auditor Hideo Yamada with inflating the company's net worth in financial statements for the fiscal years ended March 2007 and 2008, in violation of the Financial Instruments and Exchange Law. ... Full Story | Top |
Death magnifies Pradaxa hemorrhage concerns
Tue,6 Mar 2012 07:46 PM PST
Reuters - (Reuters) - The death of an elderly man from a massive brain hemorrhage after a routine fall suggests that bleeding complications from Boehringer Ingelheim's Pradaxa blood clot preventer are largely irreversible, according to the Journal of Neurosurgery. The recently approved drug is the first in a new class of oral medicines called direct thrombin inhibitors, approved to prevent strokes among patients with a dangerous irregular heartbeat called atrial fibrillation that mostly affects the elderly. U.S. ... Full Story | Top |
Japan watchdog files criminal complaint against Olympus
Tue,6 Mar 2012 05:49 PM PST
Reuters - TOKYO (Reuters) - Japan's securities watchdog became the latest authority to file a criminal complaint against Olympus Corp , some former executives and outside advisers over the company's $1.7 billion accounting fraud. The Securities Exchange and Surveillance Commission (SESC) said on Tuesday it had requested criminal charges be filed by public prosecutors against individuals involved in dubious mergers and acquisitions used to hide losses in one of Japan's biggest corporate scandals. ... Full Story | Top |
Snoring tied to kids' risk of behavioral problems: study
Tue,6 Mar 2012 05:05 PM PST
Reuters - (Reuters) - Young children who snore a lot or have other breathing problems at night may have a heightened risk of behavioral and emotional problems later in life, according to a U.S. study of more than 10,000 children. The study, published in the journal Pediatrics, is not the first to link behavioral issues to so-called sleep-disordered breathing -- where children chronically snore, mouth-breathe or seem to stop breathing for seconds at a time, known as apnea. "We didn't invent the association," said lead researcher Karen Bonuck, at New York's Albert Einstein College of Medicine. ... Full Story | Top |
Obama hits back at Limbaugh by invoking daughters
Tue,6 Mar 2012 04:45 PM PST
Reuters - WASHINGTON (Reuters) - President Barack Obama invoked his young daughters on Tuesday to hit back at Rush Limbaugh over the conservative talk show host's incendiary comments about a birth control activist. In remarks that outraged many women and drew criticism from both Democrats and Republicans, Limbaugh branded Georgetown University law student Sandra Fluke a "slut" and "prostitute" for speaking out in support of Obama's policies on birth control. Carefully measuring his words at a White House news conference, Obama would not take on Limbaugh directly or comment on his apology. ... Full Story | Top |
FDA approves Discovery Lab's lung drug, shares soar
Tue,6 Mar 2012 03:06 PM PST
Reuters - (Reuters) - Discovery Laboratories Inc said U.S. health regulators have approved its drug to prevent a breathing disorder in premature infants, sending its shares up 35 percent in extended trade. The company expects to launch its drug, Surfaxin, the first synthetic surfactant approved for the prevention of respiratory distress syndrome (RDS), later this year in the United States. RDS is a condition in which lungs of premature infants are not able to make enough surfactant, a liquid that coats the inside of the lungs and helps to keep them open. Without enough surfactant, the lungs collapse. ... Full Story | Top |
Two UK Murdoch journalists in apparent suicide bids
Tue,6 Mar 2012 03:00 PM PST
Reuters - LONDON (Reuters) - Two senior journalists working for Rupert Murdoch's News International have apparently attempted suicide as pressure mounts at the scandal-hit publisher of the now-defunct News of the World. Three sources close to the company told Reuters on Tuesday the two journalists at the Sun daily appeared to have tried to take their own lives. Investigations sparked by a phone-hacking scandal continue to expose dubious practices by present and past employees. ... Full Story | Top |
Two UK Murdoch journalists in apparent suicide bids
Tue,6 Mar 2012 02:38 PM PST
Reuters -  LONDON (Reuters) - Two senior journalists working for Rupert Murdoch's News International have apparently attempted suicide as pressure mounts at the scandal-hit publisher of the now-defunct News of the World. Three sources close to the company told Reuters on Tuesday the two journalists at the Sun daily appeared to have tried to take their own lives. Investigations sparked by a phone-hacking scandal continue to expose dubious practices by present and past employees. ...
Full Story | Top |
Death magnifies Pradaxa hemorrhage concerns
Tue,6 Mar 2012 02:19 PM PST
Reuters - (Reuters) - The death of an elderly man from a massive brain hemorrhage after a routine fall suggests that bleeding complications from Boehringer Ingelheim's Pradaxa blood clot preventer are largely irreversible, according to the Journal of Neurosurgery. The recently approved drug is the first in a new class of oral medicines called direct thrombin inhibitors, approved to prevent strokes among patients with an irregular heartbeat called atrial fibrillation that mostly affects the elderly. U.S. ... Full Story | Top |
U.S. FDA warns breathable caffeine maker over label
Tue,6 Mar 2012 02:18 PM PST
Reuters - WASHINGTON (Reuters) - U.S. regulators warned the maker of inhalable caffeine product AeroShot Pure Energy over false or misleading labeling, and for contradictory statements about using the product with alcohol. The Food and Drug Administration said Breathable Foods Inc labeled AeroShot as both inhaled and ingestible, which is contradictory and could be unsafe. The warning letter posted online Tuesday by the FDA comes after U.S. Sen. Charles Schumer urged the agency to review the safety and legality of the breathable caffeine. ... Full Story | Top |
More patients relapse in Gilead hepatitis C trial
Tue,6 Mar 2012 02:16 PM PST
Reuters - (Reuters) - Two more patients in a 10-patient segment of a mid-stage trial testing Gilead Sciences Inc's experimental hepatitis C drug GS-7977 had the virus return within four weeks of treatment, researchers said on Tuesday. The company, which recently paid nearly $11 billion to acquire the drug and its developer, Pharmasset, said last month that six out of 10 patients with a prior "null response" to standard hepatitis C therapy saw the virus return within four weeks of treatment with a combination of GS-7977 and the antiviral drug ribavirin. ... Full Story | Top |
Vertex, Merck hepatitis drugs work in HIV patients
Tue,6 Mar 2012 02:16 PM PST
Reuters - SEATTLE (Reuters) - Rival hepatitis C drugs from Merck & Co and Vertex Pharmaceuticals are effective in patients also infected with HIV, the virus that causes AIDS, according to data released on Tuesday. The Vertex drug had the more impressive results, the data showed. The results from midstage trials may raise questions about a notification last month from U.S. regulators and Merck that use of the company's Victrelis drug in such "co-infected" patients could lessen the effectiveness of some widely used medicines for human immunodeficiency virus, or HIV. ... Full Story | Top |
Mixed picture for mom, baby with antidepressants
Tue,6 Mar 2012 02:14 PM PST
Reuters - NEW YORK (Reuters Health) - Babies born to mothers who took antidepressants while they were pregnant had slightly slower head growth and were more likely to be born early, in a new study from the Netherlands. Still, that doesn't prove that the drugs, called selective serotonin reuptake inhibitors (SSRIs), caused changes in the babies' development -- or that those differences would end up having long-term effects. ... Full Story | Top |
FDA approves Discovery Lab's lung drug
Tue,6 Mar 2012 01:29 PM PST
Reuters - (Reuters) - Discovery Laboratories Inc said U.S. health regulators have approved its drug to prevent a breathing disorder in premature infants. The company expects to launch Surfaxin, which prevents respiratory distress syndrome, later this year in the United States. The U.S. Food and Drug Administration declined to approve the drug in April 2009. (Reporting by Anand Basu in Bangalore; Editing by Don Sebastian) Full Story | Top |
Many vets with PTSD prescribed opioid painkillers
Tue,6 Mar 2012 01:24 PM PST
Reuters - NEW YORK (Reuters Health) - Veterans of the Iraq and Afghanistan wars who are treated for pain are more likely to get very strong painkillers if they also have mental health problems, including post-traumatic stress disorder, according to a new study. That's worrisome, researchers said, because some people who take opioids -- which include OxyContin and Vicodin -- abuse the drugs or overdose on them, and those who already have mental troubles may be most at risk. "There's really been a culture of, 'Let's get rid of pain,' and I think unfortunately that pendulum may have swung too far," said ... Full Story | Top |
| |
|
No comments:
Post a Comment